Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trial

1. Maggiolo, F.
2. Rizzardini, G.
3. Raffi, F.
4. Pulido, F.
5. Mateo-Garcia, M.G.
6. Molina, J.-M.
7. Ong, E.
8. Shao, Y.
9. Piontkowsky, D.
10. Das, M.
11. McNicholl, I.
12. Haubrich, R.